237 related articles for article (PubMed ID: 26971793)
1. Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma.
Liu X; Sun K; Wang H; Dai Y
Cell Mol Neurobiol; 2016 Oct; 36(7):1197-208. PubMed ID: 26971793
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.
Riedel M; Struve N; Müller-Goebel J; Köcher S; Petersen C; Dikomey E; Rothkamm K; Kriegs M
Oncotarget; 2016 Sep; 7(38):61988-61995. PubMed ID: 27542273
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib exerts anti-glioma activity in vitro and in vivo.
Siegelin MD; Raskett CM; Gilbert CA; Ross AH; Altieri DC
Neurosci Lett; 2010 Jul; 478(3):165-70. PubMed ID: 20470863
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Carra E; Barbieri F; Marubbi D; Pattarozzi A; Favoni RE; Florio T; Daga A
Cell Cycle; 2013 Feb; 12(3):491-500. PubMed ID: 23324350
[TBL] [Abstract][Full Text] [Related]
5. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.
Ding X; Chaiteerakij R; Moser CD; Shaleh H; Boakye J; Chen G; Ndzengue A; Li Y; Zhou Y; Huang S; Sinicrope FA; Zou X; Thomas MB; Smith CD; Roberts LR
Oncotarget; 2016 Apr; 7(15):20080-92. PubMed ID: 26956050
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.
Yang F; Brown C; Buettner R; Hedvat M; Starr R; Scuto A; Schroeder A; Jensen M; Jove R
Mol Cancer Ther; 2010 Apr; 9(4):953-62. PubMed ID: 20371721
[TBL] [Abstract][Full Text] [Related]
9. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
[TBL] [Abstract][Full Text] [Related]
10. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
Cheng YC; Hueng DY; Huang HY; Chen JY; Chen Y
Oncotarget; 2016 May; 7(20):29116-30. PubMed ID: 27074557
[TBL] [Abstract][Full Text] [Related]
11. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C
Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts.
Lin JC; Huang WP; Liu CL; Lee JJ; Liu TP; Ko WC; Huang YC; Hsu ML; Wu CH; Chen YJ
Transplantation; 2013 Mar; 95(6):791-800. PubMed ID: 23354299
[TBL] [Abstract][Full Text] [Related]
14. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
[TBL] [Abstract][Full Text] [Related]
15. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivo.
Yuan G; Yan SF; Xue H; Zhang P; Sun JT; Li G
J Biol Chem; 2014 Apr; 289(15):10607-10619. PubMed ID: 24599950
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways.
Hao H; Zhang D; Shi J; Wang Y; Chen L; Guo Y; Ma J; Jiang X; Jiang H
Anticancer Drugs; 2016 Mar; 27(3):192-203. PubMed ID: 26629768
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
[TBL] [Abstract][Full Text] [Related]
19. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]